Drug Enforcement Administration July 2014 – Federal Register Recent Federal Regulation Documents

Franklyn Seabrooks, M.D.; Decision and Order
Document Number: 2014-17893
Type: Notice
Date: 2014-07-30
Agency: Drug Enforcement Administration, Department of Justice
Robert V. Cattani, M.D.; Decision and Order
Document Number: 2014-17892
Type: Notice
Date: 2014-07-30
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration: Fresenius Kabi USA, LLC
Document Number: 2014-17681
Type: Notice
Date: 2014-07-28
Agency: Drug Enforcement Administration, Department of Justice
Fresenius Kabi USA, LLC applied to be registered as an importer of a basic class of narcotic controlled substance. The Drug Enforcement Administration grants Fresenius Kabi USA, LLC registration as an importer of this controlled substance.
Importer of Controlled Substances Registration: Meridian Medical Technologies
Document Number: 2014-16318
Type: Notice
Date: 2014-07-14
Agency: Drug Enforcement Administration, Department of Justice
Meridian Medical Technologies applied to be registered as an importer of a certain basic class of narcotic controlled substance. The DEA grants Meridian Medical Technologies registration as an importer of this controlled substance.
Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute
Document Number: 2014-16317
Type: Notice
Date: 2014-07-14
Agency: Drug Enforcement Administration, Department of Justice
Moore Clinical Trials, L.L.C.; Decision and Order
Document Number: 2014-16162
Type: Notice
Date: 2014-07-11
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Research Triangle Institute
Document Number: 2014-16161
Type: Notice
Date: 2014-07-11
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: S & B PHARMA, INC.
Document Number: 2014-15888
Type: Notice
Date: 2014-07-08
Agency: Drug Enforcement Administration, Department of Justice
Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2015
Document Number: 2014-15549
Type: Notice
Date: 2014-07-02
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes to establish the 2015 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV
Document Number: 2014-15548
Type: Rule
Date: 2014-07-02
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Deputy Administrator of the Drug Enforcement Administration places the substance 2- [(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol (tramadol), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities with, or possess) or propose to handle tramadol.